Reports for APOTEX INC

Company Name
APOTEX INC

Shortage reports

Actual shortage:

257 (7%)

Anticipated shortage:

3 (0%)

Avoided shortage:

11 (0%)

Resolved:

3300 (92%)

3571

Discontinuation Reports

To be discontinued:

24 (7%)

Discontinued:

342 (93%)

Reversed:

0 (0%)

366

143 (4%)

32 (11%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-AMLODIPINE-ATORVASTATIN 5MG 80MG TABLET Resolved 2017-08-14 2017-10-24 19213
APO-AMLODIPINE-ATORVASTATIN 80MG 10MG TABLET Resolved 2022-06-06 2022-07-22 162091
APO-AMLODIPINE-ATORVASTATIN 10MG 80MG TABLET Resolved 2019-12-12 2020-01-22 101088
APO-AMLODIPINE-ATORVASTATIN 10MG 80MG TABLET Resolved 2019-02-13 2019-04-22 75608
APO-AMLODIPINE-ATORVASTATIN 40MG 5MG TABLET Resolved 2022-06-06 2022-07-22 162088
APO-AMLODIPINE-ATORVASTATIN 10MG 10MG TABLET Resolved 2021-05-07 2021-05-26 138951
APO-AMLODIPINE-ATORVASTATIN 80MG 10MG TABLET Resolved 2023-12-08 2024-01-19 212940
APO-AMLODIPINE-ATORVASTATIN 10MG 40MG TABLET Resolved 2019-12-12 2020-01-15 101082
APO-AMLODIPINE-ATORVASTATIN 80MG 10MG TABLET Resolved 2022-03-18 2022-04-01 156983
APO-AMLODIPINE-ATORVASTATIN 10MG 40MG TABLET Resolved 2020-07-08 2020-07-13 119683
APO-AMLODIPINE-ATORVASTATIN 80MG 5MG TABLET Resolved 2023-07-07 2023-09-01 197872
APO-AMLODIPINE-ATORVASTATIN 10MG 10MG TABLET Resolved 2017-06-08 2017-08-08 12278
APO-AMLODIPINE-ATORVASTATIN 40MG 10MG TABLET Resolved 2022-12-02 2023-03-02 176924
APO-AMLODIPINE-ATORVASTATIN 5MG 10MG TABLET Resolved 2018-02-01 2018-07-03 37945
APO-AMLODIPINE-ATORVASTATIN 80MG 5MG TABLET Resolved 2021-05-07 2021-05-26 138954
APO-AMLODIPINE-ATORVASTATIN 5MG 40MG TABLET Resolved 2021-04-23 2021-05-26 137956
APO-AMLODIPINE-ATORVASTATIN 20MG 10MG TABLET Resolved 2021-10-01 2021-11-15 146500
APO-AMLODIPINE-ATORVASTATIN 80MG 10MG TABLET Resolved 2021-08-27 2021-11-19 144656
APO-AMLODIPINE-ATORVASTATIN 80MG 10MG TABLET Resolved 2023-02-16 2023-03-02 185025
APO-AMLODIPINE-ATORVASTATIN 5MG 80MG TABLET Resolved 2018-01-31 2018-07-03 37717
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-QUETIAPINE 25MG TABLET Discontinued 2020-07-10 2020-07-10 119950
APO-QUININE 300MG CAPSULE Discontinued 2018-09-08 2021-05-10 60714
APO-QUININE 200MG CAPSULE Discontinued 2018-09-08 2021-05-10 60711
APO-RABEPRAZOLE 20MG TABLET (ENTERIC-COATED) Discontinued 2018-09-08 2018-10-05 60717
APO-RABEPRAZOLE 10MG TABLET (ENTERIC-COATED) Discontinued 2019-01-04 2019-01-04 71204
APO-RABEPRAZOLE 20MG TABLET (ENTERIC-COATED) Discontinued 2019-01-04 2019-01-04 71201
APO-RABEPRAZOLE 10MG TABLET (ENTERIC-COATED) Discontinued 2018-02-23 2019-09-12 40805
APO-RAMIPRIL 1.25MG CAPSULE Discontinued 2018-09-08 2019-03-29 60720
APO-RANITIDINE TABLET 150MG 150MG TABLET Discontinued 2018-09-08 2019-02-13 60723
APO-RANITIDINE TABLET 150MG 150MG TABLET Discontinued 2018-09-08 2018-12-28 60726
APO-RANITIDINE TABLET 150MG 150MG TABLET Discontinued 2019-01-02 2019-01-09 70810
APO-RANITIDINE TABLET 300MG 300MG TABLET Discontinued 2018-09-08 2018-09-15 60729
APO-RANITIDINE TABLET 300MG 300MG TABLET To be discontinued 2018-09-08 2018-09-08 60732
APO-REPAGLINIDE Discontinued 2018-09-08 2018-09-15 60741
APO-REPAGLINIDE Discontinued 2018-09-08 2018-09-15 60735
APO-REPAGLINIDE Discontinued 2018-09-08 2018-09-15 60738
APO-RILUZOLE 50MG TABLET To be discontinued 2018-09-08 2018-09-08 60744
APO-RISEDRONATE 35MG TABLET Discontinued 2018-09-08 2018-09-15 60747
APO-RISEDRONATE 35MG TABLET Discontinued 2018-10-19 2018-10-19 64965
APO-RISPERIDONE 1MG SOLUTION To be discontinued 2019-03-11 2019-03-11 78260